Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakesh C Kukreja

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Journal of Molecular and Cellular Cardiology|October 24, 2002
NFkappaB activation during ischemia/reperfusion in heart: friend or foe?Rakesh C Kukreja
Current Pharmaceutical Design|April 18, 2013
Sildenafil and cardioprotectionRakesh C Kukreja
American Journal of Physiology. Heart and Circulatory Physiology|January 29, 2017
Myriad roles of voltage-activated potassium channel subunit Kvβ1.1 in the heartRakesh C Kukreja
Cardiovascular Drugs and Therapy|March 15, 2006
Synergistic effects of atorvastatin and sildenafil in cardioprotection--role of NORakesh C Kukreja
Circulation|July 26, 2012
Phosphodiesterase-5 and retargeting of subcellular cGMP signaling during pathological hypertrophyRakesh C Kukreja
American Journal of Physiology. Heart and Circulatory Physiology|August 1, 2006
Mechanism of reactive oxygen species generation after opening of mitochondrial KATP channelsRakesh C Kukreja
Journal of the American Heart Association|December 19, 2014
Ataxia-telangiectasia mutated kinase: a potential new target for suppressing inflammation in heart failure?Rakesh C Kukreja
Molecular and Cellular Pharmacology|April 19, 2011
Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 InhibitorSaisudha Koka, Rakesh C Kukreja
Journal of Molecular and Cellular Cardiology|December 19, 2006
eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?Rakesh C Kukreja, Lei Xi
Cardiovascular Drugs and Therapy|December 6, 2023
Beyond Hepatoprotection-The Cardioprotective Effects of Bicyclol in DiabetesArun Samidurai, Rakesh C Kukreja
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Journal of Molecular and Cellular Cardiology|October 24, 2002
NFkappaB activation during ischemia/reperfusion in heart: friend or foe?Rakesh C Kukreja
Current Pharmaceutical Design|April 18, 2013
Sildenafil and cardioprotectionRakesh C Kukreja
American Journal of Physiology. Heart and Circulatory Physiology|January 29, 2017
Myriad roles of voltage-activated potassium channel subunit Kvβ1.1 in the heartRakesh C Kukreja
Cardiovascular Drugs and Therapy|March 15, 2006
Synergistic effects of atorvastatin and sildenafil in cardioprotection--role of NORakesh C Kukreja
Circulation|July 26, 2012
Phosphodiesterase-5 and retargeting of subcellular cGMP signaling during pathological hypertrophyRakesh C Kukreja
American Journal of Physiology. Heart and Circulatory Physiology|August 1, 2006
Mechanism of reactive oxygen species generation after opening of mitochondrial KATP channelsRakesh C Kukreja
Journal of the American Heart Association|December 19, 2014
Ataxia-telangiectasia mutated kinase: a potential new target for suppressing inflammation in heart failure?Rakesh C Kukreja
Molecular and Cellular Pharmacology|April 19, 2011
Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 InhibitorSaisudha Koka, Rakesh C Kukreja
Journal of Molecular and Cellular Cardiology|December 19, 2006
eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?Rakesh C Kukreja, Lei Xi
Cardiovascular Drugs and Therapy|December 6, 2023
Beyond Hepatoprotection-The Cardioprotective Effects of Bicyclol in DiabetesArun Samidurai, Rakesh C Kukreja
Pageof 13